Drugs / imidazolylethanamide of pentanedioic acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07645534 | Jul 2025 → Dec 2027 expected | influenza | Valenta Pharm JSC | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | imidazolylethanamide of pentanedioic acid | “Ingavirin containing 90 mg of imidazolylethanamide of pentanedioic acid” NCT07645534 ↗ |